The Coffee Shop Origins of Factor V Leiden – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“Read our full profile on Frits Rosendaal, the 2026 ISTH Grant Medal recipient, and learn more about his life, including this anecdote:
How did they decide on the name Factor V Leiden for the mutation?
Rosendaal recalled the memory with a smile.’We were all gathered in the hospital coffee shop in the lobby. This was at a time when you were still allowed to drink beer and smoke in a hospital, so we were sitting there enjoying a drink and discussing how we should publicize it,’ he said.
Naming conventions for variant proteins often followed geography, typically the hometown of the first identified patient.
But in this case, there was no single ‘first patient,’ as the mutation had been identified through group studies.
So the team improvised with a bit of humor.
They joked that the first patient could have come from a nearby Dutch town but decided the international community might struggle with the pronunciation.
Instead, they chose a simpler, more recognizable name tied to their own institution:
Factor V Leiden, a name that ultimately stuck and became standard worldwide.

Stay updated with Hemostasis Today.
-
Jun 27, 2026, 18:19Nabil Tabish: The Paradox of Zero – Investigating Extreme VWF Discordance
-
Jun 27, 2026, 18:19Francesco Favruzzo: Can Mechanical Thrombectomy Be Safely Used in Cervical Artery Dissection?
-
Jun 27, 2026, 18:18Vera Ghali: 2026 ASH–ISTH Recommendations on Pediatric VTE Prevention
-
Jun 27, 2026, 18:17Michiel Coppens: A Hemostasis Laboratory – One of the Cornerstones of Our Hemophilia Mission
-
Jun 27, 2026, 18:16Sthanu Subramanian: Dabigatran and Mechanical Heart Valves
-
Jun 27, 2026, 15:50Muhammet Özbilen: The Skin as an Emerging Regulator of Iron Homeostasis
-
Jun 27, 2026, 15:07Anteneh Berhane: Supporting Healthier Pregnancies Through Early Nutrition
-
Jun 27, 2026, 14:35Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
-
Jun 27, 2026, 14:01Abdul Mannan: DOACs in Cancer-Associated VTE – When to Avoid Them, And When LMWH Wins